Adage Capital Partners’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Sell |
200,000
-1,350,000
| -87% | -$1.93M | ﹤0.01% | 822 |
|
|
2025
Q1 | $2.48M | Hold |
1,550,000
| – | – | ﹤0.01% | 751 |
|
|
2024
Q4 | $5.58M | Buy |
1,550,000
+1,030,000
| +198% | +$3.71M | 0.01% | 706 |
|
|
2024
Q3 | $2.96M | Buy |
+520,000
| New | +$2.96M | 0.01% | 758 |
|
|
2022
Q1 | – | Sell |
-996,477
| Closed | -$32.1M | – | 1087 |
|
|
2021
Q4 | $32.1M | Buy |
996,477
+185,000
| +23% | +$5.96M | 0.06% | 331 |
|
|
2021
Q3 | $36.3M | Buy |
811,477
+121,477
| +18% | +$5.43M | 0.07% | 278 |
|
|
2021
Q2 | $26.1M | Sell |
690,000
-190,498
| -22% | -$7.21M | 0.05% | 374 |
|
|
2021
Q1 | $32.6M | Sell |
880,498
-10,000
| -1% | -$370K | 0.07% | 313 |
|
|
2020
Q4 | $29.5M | Buy |
+890,498
| New | +$29.5M | 0.06% | 318 |
|